Table 2: Evaluation of Genetic Animal Models of OCD

Genetic Model Face Validity* CSTC Circuit Expression^ CSTC Synaptic Dysfunction Response to SSRIs
D1CT Tg +++ ++ ++ nd
Hoxb8 mutant +++ +++ nd nd
5-HT2C null + + nd nd
ArKO ++ ? nd nd
DAT KD + +++ +++ nd
SAPAP3 null +++ +++ +++ ++

D1CT Tg, transgenic mouse line in which neuropotentiating cholera toxin is expressed under the D1-type dopamine receptor promoter elements; Hoxb8 mutant, homozygous loss-of-function for mammalian transcription factor Hoxb8; 5-HT2C null, null mutant mouse for the 5-HT2C subtype of the serotonin receptor; ArKO (for aromatase knock-out), estrogen deficient mouse line resulting from elimination of aromatase expression; DAT KD, dopamine transporter knock-down mice with DAT levels reduced to 10% of wild-type values; SAPAP3 null, null mutant mouse for the postsynaptic scaffolding protein SAPAP3.
* Note that face validity incorporates both behavioral similarity AND specificity.
^ CSTC circuit expression refers to the extent to which the gene or Tg is expressed in these brain regions.
nd - not demonstrated.